Overview
Betamethasone Valerate is a potent corticosteroid active pharmaceutical ingredient (API) in the Corticosteroid therapeutic category. It is widely used in topical, ophthalmic, oral, and parenteral formulations for its anti-inflammatory and immunosuppressive properties. Manufactured to IP / BP / USP / EP pharmacopoeial standards.
Therapeutic Application
Betamethasone Valerate is a moderately potent topical corticosteroid used in the treatment of inflammatory skin conditions including eczema, psoriasis, and dermatitis.
Specifications
- CAS Number: 2152-44-5
- Appearance: White to off-white crystalline powder
- Typical Assay/Purity: ≥ 99.0%
- Common Pharmacopeial Grades: IP / BP / USP / EP
- Storage: Store in a cool, dry place, away from light
- Shelf Life: Typically 24 months under recommended storage conditions
Regulatory & Compliance
Pharmint Exports adheres to WHO-GMP manufacturing practices, ensuring that Betamethasone Valerate is produced in compliance with international quality standards. DMF Status: CEP Planned. Approved regulatory authorities/registrations: ANVISA, KFDA. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.
Packaging & Shipping
Betamethasone Valerate is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including EU, USA, Brazil, China, South Korea, Taiwan, Middle East.
Common Use Cases & Finished Dosage Forms
This API is typically incorporated into various dosage forms including:
- Tablets
- Capsules
- Injectable solutions
Ordering Information
The minimum order quantity (MOQ) for Betamethasone Valerate is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Pharmint Exports directly.











Reviews
There are no reviews yet.